The investment company of the Sandoz family, Emasan AG, has divested a substantial portion of its holdings in Swiss pharmaceutical giant Novartis. Through an accelerated bookbuilding process, 26.5 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback